H, D., B, C., C, C., A, J., C, D. C., M, L., . . . MC, V. (2023). Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1. Journal of the Endocrine Society, 7(8), bvad083. https://doi.org/10.1210/jendso/bvad083
Chicago Style (17th ed.) CitationH, Dupuis, et al. "Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1." Journal of the Endocrine Society 7, no. 8 (2023): bvad083. https://doi.org/10.1210/jendso/bvad083.
MLA (9th ed.) CitationH, Dupuis, et al. "Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1." Journal of the Endocrine Society, vol. 7, no. 8, 2023, p. bvad083, https://doi.org/10.1210/jendso/bvad083.